RepeatAnalyzer improves scientists' ability to identify, manage bacterial strains

NewsGuard 100/100 Score

Washington State University researchers have developed a new software tool that will improve scientists' ability to identify and understand bacterial strains and accelerate vaccine development.

RepeatAnalyzer is able to track, manage, analyze and catalogue the short, repeating sequences of bacterial DNA.

The researchers used the software to characterize Anaplasma marginale, a tick-borne bacteria that affects cattle, and published their work in the journal BMC Genomics. The research team includes computer science student Helen Catanese; Kelly Brayton, Department of Veterinary Microbiology and Pathology; and Assefaw Gebremedhin, School of Electrical Engineering and Computer Science.

Like many types of bacterial pathogens, A. marginale has a huge variety of strains and is widely distributed geographically, which makes vaccine development challenging. Scientists use short repeating sequences of DNA, called repeats, to understand the bacteria, its heredity and geographic distribution and to determine how harmful it is.

But for A. marginale, for instance, researchers have found more than 235 short, repeating DNA sequences. Without any kind of database, researchers had to mine published literature to keep track of the sequences. The task is also error prone when done manually, said Brayton.

"We developed RepeatAnalyzer precisely to bridge that gap," said Gebremedhin.

They developed the software for A. marginale, but it can be extended to any other species with similar repeating DNA sequences. It also provides a visualization tool so researchers can track strains on a world map, said Catanese.

"This reliable software tool can fuel research and collaboration and accelerate the path to the discovery of a vaccine," said Gebremedhin.

RepeatAnalyzer has garnered significant interest, and Brayton's collaborators in South Africa and China are already using it, she said.

"Here is something that was overlooked and didn't exist,'' said Gebremedhin. "More than anything, it will help people. When you have a tool, and the right metrics and analysis, you may find things you might not have known before.''

The researchers are working to extend the software to collect and handle similar datasets on other bacteria, as well as expanding on the visualization and analysis functionalities.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses